1h Free Analyst Time
The biochips market is forecasted to grow by USD 72.27 billion during 2023-2028, accelerating at a CAGR of 30.73% during the forecast period. The report on the biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications of microarray biochips in drug discovery, increase in market presence of market players with collaboration strategy, and growing use of personalized medicines.
The biochips market is segmented as below:
By End-user
- Biotechnology and pharmaceutical companies
- Hospitals and diagnostics centers
- Academic and research institutes
By Technology
- Microarrays
- Microfluidics
By Geographical Landscape
- North America
- Europe
- APAC
- Middle East and Africa
- South America
The report on the biochips market covers the following areas:
- Biochips market sizing
- Biochips market forecast
- Biochips market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global biochips market: Agilent Technologies Inc., Analis sa, Arrayit Corp., BICO Group AB, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., Dynamic Biosensors GmbH, Eden Tech, Greiner Bio One International GmbH, IDEX Corp., Illumina Inc., INNOPSYS, Micronit BV, Nutcracker Therapeutics Inc., Perkin Elmer Inc., QIAGEN NV, Randox Laboratories Ltd., Sphere Fluidics Ltd., Takara Holdings Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing use of chemical microarray technology."
According to the report, one of the major drivers for this market is the growing applications of microarray biochips in drug discovery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Analis sa
- Arrayit Corp.
- BICO Group AB
- Bio Rad Laboratories Inc.
- Boao Bio Group Co. Ltd.
- Dynamic Biosensors GmbH
- Eden Tech
- Greiner Bio One International GmbH
- IDEX Corp.
- Illumina Inc.
- INNOPSYS
- Micronit BV
- Nutcracker Therapeutics Inc.
- Perkin Elmer Inc.
- QIAGEN NV
- Randox Laboratories Ltd.
- Sphere Fluidics Ltd.
- Takara Holdings Inc.
- Thermo Fisher Scientific Inc.
